{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:48:19Z","timestamp":1761540499487},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1309\/2d6f-rr03-8efn-28f5","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T14:42:18Z","timestamp":1082040138000},"page":"269-276","source":"Crossref","is-referenced-by-count":18,"title":["Identification of von Willebrand Disease Type 2N (Normandy) in Australia"],"prefix":"10.1093","volume":"118","author":[{"given":"Susan E.","family":"Rodgers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy V.","family":"Lerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme J.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hertzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,8,1]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","author":"Sadler, JE","year":"1998","unstructured":"Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424.","journal-title":"Annu Rev Biochem"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","author":"Nishino, M","year":"1989","unstructured":"Nishino M, Girma J-P, Rothschild C, et al. New variant of von Willebrand disease with defective binding to factor VIII. Blood. 1989;74:1591-1599.","journal-title":"Blood"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0038-1650401","volume":"75","author":"Nesbitt","year":"1996","unstructured":"Nesbitt IM, Goodeve AC, Guilliatt AM, et al. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques. Thromb Haemost. 1996;75:959-964.","journal-title":"Thromb Haemost"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-0038-1650628","volume":"76","author":"Schneppenheim","year":"1996","unstructured":"Schneppenheim R, Budde U, Krey S, et al. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb Haemost. 1996;76:598-602.","journal-title":"Thromb Haemost"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2141.1998.00940.x","volume":"103","author":"Casonato","year":"1998","unstructured":"Casonato A, Gaucher C, Pontara E, et al. Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene. Br J Haematol. 1998;103:39-41.","journal-title":"Br J Haematol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0037-1614375","volume":"82","author":"in Haematology Haemostasis Scientific Advisory","year":"1999","unstructured":"Favaloro EJ, Smith J, Petinos P, et al, for the RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thromb Haemost. 1999;82:1276-1282.","journal-title":"Thromb Haemost"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00001721-200012000-00006","volume":"11","author":"Emerging Technologies","year":"2000","unstructured":"Favaloro EJ, Thom J, Baker R, for the Australasian Society for Thrombosis and Haemostasis (ASTH) Emerging Technologies Group. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey. Blood Coagul Fibrinolysis. 2000;11:729-737.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1365-2141.1994.tb06749.x","author":"Duncan, EM","year":"1994","unstructured":"Duncan EM, Duncan BM, Tunbridge LJ, et al. Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. Br J Haematol. 1994;87:846-848.","journal-title":"Br J Haematol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V60.1.201.201","author":"Montgomery, RR","year":"1982","unstructured":"Montgomery RR, Hathaway WE, Johnson J, et al. A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood. 1982;60:201-207.","journal-title":"Blood"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2257.1980.tb00839.x","author":"Denson, KWE","year":"1980","unstructured":"Denson KWE, Wilkins T. Semi-automation of the two-stage factor VIII assay. Clin Lab Haematol. 1980;2:311-316.","journal-title":"Clin Lab Haematol"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/00313029309084791","author":"Favaloro, EJ","year":"1993","unstructured":"Favaloro EJ, Grispo L, Dinale A, et al. von Willebrand's disease: laboratory investigation using an improved functional assay for von Willebrand factor. Pathology. 1993;25:152-158.","journal-title":"Pathology"},{"key":"E00012","first-page":"127","author":"Favaloro, EJ","year":"2000","unstructured":"Favaloro EJ. Collagen binding assay for von Willebrand factor (vWF:CBA): detection of von Willebrand's disease (vWD), and discrimination of vWD subtypes, depends on collagen source. Thromb Haemost. 2000;83:127-135.","journal-title":"Thromb Haemost"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","author":"Mancuso, DJ","year":"1989","unstructured":"Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem. 1989;264:19514-19527.","journal-title":"J Biol Chem"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.V97.3.685","volume":"97","author":"Pipe","year":"2001","unstructured":"Pipe SW, Saenko EL, Eickhorst AN, et al. Hemophilia A mutations associated with 1-stage\/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood. 2001;97:685-691.","journal-title":"Blood"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1650567","volume":"76","author":"Mazurier","year":"1996","unstructured":"Mazurier C, Meyer D. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease: results of an international survey. Thromb Haemost. 1996;76:270-274.","journal-title":"Thromb Haemost"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1016\/S0021-9258(18)54972-3","volume":"266","author":"Kroner","year":"1991","unstructured":"Kroner PA, Friedman KD, Fahs SA, et al. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem. 1991;266:19146-19149.","journal-title":"J Biol Chem"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V87.3.1013.bloodjournal8731013","volume":"87","author":"Kroner","year":"1996","unstructured":"Kroner PA, Foster PA, Fahs SA, et al. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood. 1996;87:1013-1021.","journal-title":"Blood"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","volume":"88","author":"Mazurier","year":"1994","unstructured":"Mazurier C, Gaucher C, Jorieux S, et al. Biological effect of desmopressin in eight patients with type 2N (\"Normandy\") von Willebrand disease. Br J Haematol. 1994;88:849-854.","journal-title":"Br J Haematol"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1055\/s-0037-1614329","volume":"82","author":"Nesbitt","year":"1999","unstructured":"Nesbitt IM, Hampton KK, Preston FE, et al. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations. Thromb Haemost. 1999;82:1061-1064.","journal-title":"Thromb Haemost"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","volume":"95","author":"Allen","year":"2000","unstructured":"Allen S, Abuzenadah AM, Blagg JL, et al. Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor. Blood. 2000;95:2000-2007.","journal-title":"Blood"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajcp\/109.3.347","author":"Casanato, A","year":"1998","unstructured":"Casanato A, Pontara E, Zerbinati P, et al. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol. 1998;109:347-352.","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/118\/2\/269\/4985152\/ajcpath118-0269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T17:01:40Z","timestamp":1623776500000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/2D6F-RR03-8EFN-28F5"}},"subtitle":["A Cross-Laboratory Investigation Using Different Methods"],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2002,8,1]]},"published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1309\/2D6F-RR03-8EFN-28F5"],"URL":"https:\/\/doi.org\/10.1309\/2d6f-rr03-8efn-28f5","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}